Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Stifel Financial Corp (SF)

Stifel Financial Corp (SF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 9,179,032
  • Shares Outstanding, K 102,456
  • Annual Sales, $ 4,349 M
  • Annual Income, $ 522,540 K
  • 60-Month Beta 1.09
  • Price/Sales 2.09
  • Price/Cash Flow 10.86
  • Price/Book 1.86
Trade SF with:

Options Overview Details

View History
  • Implied Volatility 24.05% ( -1.71%)
  • Historical Volatility 24.13%
  • IV Percentile 48%
  • IV Rank 44.83%
  • IV High 38.85% on 08/05/24
  • IV Low 12.03% on 08/22/24
  • Put/Call Vol Ratio 0.21
  • Today's Volume 312
  • Volume Avg (30-Day) 111
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 3,829
  • Open Int (30-Day) 3,067

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 7 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/24
See More
  • Average Estimate 1.65
  • Number of Estimates 1
  • High Estimate 1.65
  • Low Estimate 1.65
  • Prior Year 0.60
  • Growth Rate Est. (year over year) +175.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.28 +10.70%
on 09/11/24
90.91 -1.02%
on 09/18/24
+4.41 (+5.15%)
since 08/16/24
3-Month
76.64 +17.41%
on 08/05/24
90.91 -1.02%
on 09/18/24
+8.89 (+10.96%)
since 06/18/24
52-Week
54.81 +64.17%
on 10/25/23
90.91 -1.02%
on 09/18/24
+24.24 (+36.87%)
since 09/18/23

Most Recent Stories

More News
Why Relay Therapeutics Plummeted by Nearly 14% Today

Investors weren't happy with the company's latest effort at capital-raising.

GS : 484.58 (-0.17%)
BAC : 39.62 (+0.18%)
SF : 89.98 (+0.44%)
RLAY : 7.58 (-0.26%)
Here's Why Birkenstock Stock Dropped Nearly 16% Last Month

When valuations are high, even little things can lead to disappointment.

SF : 89.98 (+0.44%)
BIRK : 48.24 (unch)
Are Wall Street Analysts Predicting Fastenal Stock Will Climb or Sink?

Fastenal has underperformed the broader market over the past year, and Wall Street analysts remain skeptical about the stock’s prospects.

FAST : 70.47 (-0.17%)
$SPX : 5,618.26 (-0.29%)
XLI : 131.85 (-0.08%)
SF : 89.98 (+0.44%)
Iovance Biotherapeutics Attracted a Downgrade. Is It Time to Sell?

Find out how concerned investors should be about setbacks for this company's revolutionary new cancer therapies.

MRK : 118.64 (+0.30%)
PIPR : 275.37 (+0.42%)
SF : 89.98 (+0.44%)
IOVA : 10.17 (-2.40%)
Stifel: Q2 Earnings Snapshot

Stifel: Q2 Earnings Snapshot

SF : 89.98 (+0.44%)
Stifel: Q1 Earnings Snapshot

Stifel: Q1 Earnings Snapshot

SF : 89.98 (+0.44%)
Why Summit Therapeutics Stock Crushed the Market This Week

The company was a standout in the biotech field, rising by nearly 23% over the period.

SF : 89.98 (+0.44%)
SMMT : 24.56 (-6.33%)
Why Viking Therapeutics Stock Was Rocketing Higher This Week

Good news from the lab and subsequent price target lifts by analysts put some zip into the company's shares.

SF : 89.98 (+0.44%)
OPY : 50.09 (-1.03%)
VKTX : 64.45 (+2.40%)
Why Lucid Stock Is Soaring Today

Lucid is receiving another major injection of capital.

LCID : 3.64 (-3.70%)
SF : 89.98 (+0.44%)
Stifel: Q4 Earnings Snapshot

Stifel: Q4 Earnings Snapshot

SF : 89.98 (+0.44%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Business Summary

Stifel Financial Corp. is a holding company for Stifel Nicolaus & Company,Incorporated.

See More

Key Turning Points

3rd Resistance Point 93.13
2nd Resistance Point 92.02
1st Resistance Point 91.00
Last Price 89.98
1st Support Level 88.87
2nd Support Level 87.76
3rd Support Level 86.74

See More

52-Week High 90.91
Last Price 89.98
Fibonacci 61.8% 77.12
Fibonacci 50% 72.86
Fibonacci 38.2% 68.60
52-Week Low 54.81

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar